Released Oct 21, 2025, after the close
10-Q filed Oct 22, 2025, 22 days after period end · 0001035267-25-000209
Q3 2025 · 10-Q
Revenue$2.51B$2.51B +22.9% vs Q3 2024+2.7% vs Q2 2025
Net Income$704.40M$704.40M +24.7% vs Q3 2024+7.0% vs Q2 2025
EPS Diluted$1.95$1.95 +25.0% vs Q3 2024+7.7% vs Q2 2025
Gross Profit$1,662,400,000+21.0%
Operating Income$759,700,000+31.6%
Operating Cash Flowderived$841,000,000+19.0%
Free Cash Flowderived$735,600,000+60.4%
Margins · derived
Gross margin66.4%−1.1 pt vs Q3 2024
Operating margin30.3%+2.0 pt vs Q3 2024
Net margin28.1%+0.4 pt vs Q3 2024
What the release said
The release
Same quarter
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $2.51B | $2.04B | $1.74B | $1.56B |
| Net Income | $704.40M | $565.10M | $415.70M | $324.00M |
| EPS Diluted | $1.95 | $1.56 | $1.16 | $0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR